Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes https://www.medrxiv.org/content/10.1101/2023.08.04.23293636
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes https://www.medrxiv.org/content/10.1101/2023.08.04.23293636